A Multi-center Study to Evaluate the Pharmacokinetics of Diacerein and Rhein and the Safety of Diacerein after Maximum Use, Topical Administration of CCP-020 (Diacerein 1% ointment) to Patients with Epidermolysis Bullosa (EB)

Category Primary study
Registry of TrialsOverview of Medical Research in the Netherlands
Year 2018
This article has no abstract
Epistemonikos ID: 9729d55b374c071b0f539ebe3fee078cb3eb73f7
First added on: Apr 11, 2025